Find therapies in clinical trials near you – page 254

Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

Study of Pertuzumab and Trastuzumab for Patients with Solid Malignant Tumors from Previous Pertuzumab Trials

Study of Pertuzumab and Trastuzumab for Patients with Solid Malignant Tumors from Previous Pertuzumab Trials

Study on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments

Study on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments

Study of SKB264 for Patients with Advanced Solid Tumors Not Responding to Standard Treatments

Study of SKB264 for Patients with Advanced Solid Tumors Not Responding to Standard Treatments

Study on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism

Study on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism

Study on the Effects of Selpercatinib in Children with Advanced RET-Altered Solid Tumors or Primary Central Nervous System Tumors

Study on the Effects of Selpercatinib in Children with Advanced RET-Altered Solid Tumors or Primary Central Nervous System Tumors

Study on Ianalumab for Patients with Systemic Lupus Erythematosus

Study on Ianalumab for Patients with Systemic Lupus Erythematosus

Study on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension

Study on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension

Study Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma

Study Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma

Long-Term Safety Study of Valoctocogene Roxaparvovec for Patients with Severe Hemophilia A

Long-Term Safety Study of Valoctocogene Roxaparvovec for Patients with Severe Hemophilia A

Study on Vedolizumab for Children with Moderate to Severe Ulcerative Colitis

Study on Vedolizumab for Children with Moderate to Severe Ulcerative Colitis

Study Comparing Lorlatinib and Crizotinib for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer

Study Comparing Lorlatinib and Crizotinib for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer